Side effects such as loss of vision, high blood pressure, slow heartbeat, and pancreatitis may occur with the use of Bugatinib.
Bugatinib is an anticancer drug that is used in the treatment of alk-positive non-small cell lung cancer patients who are resistant to crizotinib, to interfere with the growth and spread of cancer cells in the body. Some patients may experience a certain degree of vision loss, high blood pressure, slow heartbeat, pancreatitis and other side effects during the use of the drug.
Patients who are allergic to buclatinib should not use the drug. Before using the drug, the patient’s fasting blood glucose status should be evaluated, and the patient’s heart rate status should be monitored in time to avoid serious complications during the process of using the drug.
If patients experience serious discomfort during treatment, they should communicate with the attending physician and take appropriate measures to alleviate the discomfort.
Please strictly follow the doctor’s instructions and do not use medication on your own.